Both in Biotechnology
Candel Therapeutics vs Aura Biosciences
Over the past year CADL returned +76.4% and AURA returned +17.1%; their daily moves had a correlation of 0.40.
CADL +76.4% AURA +17.1%Growth of $1, one year, split-adjusted
| Metric | CADL | AURA |
|---|---|---|
| Price | $9.05 | $6.65 |
| Market cap | $692.5M | $689.6M |
| Today | +2.61% | +6.57% |
| 1 month | −8.3% | +7.8% |
| 6 months | +18.6% | −19.8% |
| Year to date | +60.2% | +22.0% |
| 1 year | +73.4% | +10.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $153.7M | $323.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 42.3% |
| Short % of float | 21.5% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).